Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery - Top-Institutions - MDSpire

Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery

  • By

  • Martin Kallab

  • Sarah Hinterberger

  • Sophie Schneider

  • Olivia Murauer

  • Anna-Sophie Reisinger

  • Susanne Strohmaier

  • Alex S. Huang

  • Matthias Bolz

  • Clemens A. Strohmaier

  • April 23, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Glaucoma Surgery
    • Ocular Imaging

  • #2

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Anterior Segment Imaging

  • #3

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Glaucoma Surgery
    • Ocular Imaging

  • #4

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, England

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Imaging Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Biomedical Imaging

Original Source(s)

Anterior Segment OCT Biomarkers in Early Postoperative Phase Show No Predictive Value for Secondary Interventions Following Preserflo MicroShunt Surgery

  • by Martin Kallab, Sarah Hinterberger, Sophie Schneider, Olivia Murauer, Anna-Sophie Reisinger, Susanne Strohmaier, Alex S. Huang, Matthias Bolz, Clemens A. Strohmaier

  • April 23, 2026

Related Content

Hydrus®: The Long-Term Evidence

Professor Gus Gazzard* outlines the five-year results of the HORIZON study, evaluating the safety and efficacy of the Hydrus® Microstent

  • April 24, 2026

  • 5 min
Glaucoma Surgery During Pregnancy

ASCRS 2026: Gonioscopy Still Matters

At the ASCRS Subspecialty Day, Ramya Swamy, MD explained that, despite advances in imaging, direct visualization of the angle remains central to care

  • April 14, 2026

  • 3 min